These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 8175295

  • 1. [Hydroxymethylglutaryl coenzyme A reductase inhibitors].
    Schuff-Werner P.
    Internist (Berl); 1994 Mar; 35(3):288-94; discussion 295. PubMed ID: 8175295
    [No Abstract] [Full Text] [Related]

  • 2. [HMG-CoA reductase inhibitors in therapy of disorders of lipid metabolism].
    Windler E, Greten H.
    Internist (Berl); 1993 Dec; 34(12):1107-14. PubMed ID: 8106206
    [No Abstract] [Full Text] [Related]

  • 3. [Coronary heart disease patient after myocardial infarct. Must LDL cholesterol now be reduced to 70 mg/dl?]].
    MMW Fortschr Med; 2005 Dec 08; 147(49-50):17-8. PubMed ID: 16401004
    [No Abstract] [Full Text] [Related]

  • 4. When a statin fails.
    Med Lett Drugs Ther; 2009 Jul 27; 51(1317):58-60. PubMed ID: 19636290
    [No Abstract] [Full Text] [Related]

  • 5. Choice of lipid-regulating drugs.
    Med Lett Drugs Ther; 2001 May 28; 43(1105):43-8. PubMed ID: 11378632
    [No Abstract] [Full Text] [Related]

  • 6. Don't trust an LDL over 70?
    Aronow WS.
    Geriatrics; 2004 May 28; 59(5):12-3. PubMed ID: 15152729
    [No Abstract] [Full Text] [Related]

  • 7. [Prevention and treatment of coronary heart disease: lowering LDL, increasing HDL or monitoring both?].
    Windler E.
    Internist (Berl); 1996 Jun 28; 37(6):643-6. PubMed ID: 8768000
    [No Abstract] [Full Text] [Related]

  • 8. [Indications for decreasing lipid values. Patients with healthy hearts with low HDL clearly profit].
    MMW Fortschr Med; 2000 Nov 30; 142(48):68. PubMed ID: 11138292
    [No Abstract] [Full Text] [Related]

  • 9. [New statin introduction. With more power against hypercholesterolemia].
    MMW Fortschr Med; 2002 Dec 12; 144(50):64. PubMed ID: 14610873
    [No Abstract] [Full Text] [Related]

  • 10. [Drug treatment of hyperlipidemia].
    Zazgornik J, Koch S.
    Wien Med Wochenschr Suppl; 1989 Dec 12; 105():20-3. PubMed ID: 2694628
    [Abstract] [Full Text] [Related]

  • 11. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).
    Lim PO, Yee KM.
    Circulation; 1999 Aug 10; 100(6):686. PubMed ID: 10441109
    [No Abstract] [Full Text] [Related]

  • 12. New options in lipid management--can we extend the benefits of current therapy? Introduction.
    Gotto AM, Paoletti R.
    Am Heart J; 2002 Dec 10; 144(6 Suppl):S19-20. PubMed ID: 12486411
    [No Abstract] [Full Text] [Related]

  • 13. Drug therapy of severe hypercholesterolemia.
    Weizel A, Richter WO.
    Eur J Med Res; 1997 Jun 16; 2(6):265-9. PubMed ID: 9182654
    [Abstract] [Full Text] [Related]

  • 14. [Big gaps in coronary heart disease prevention. Statins are not enough in dyslipidemia].
    MMW Fortschr Med; 2009 Nov 12; 151(46):48. PubMed ID: 20043395
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of dyslipoproteinemia risk factor. Lipid therapy must become multidimensional].
    MMW Fortschr Med; 2008 Jun 26; 150(26-27):52-3. PubMed ID: 18681233
    [No Abstract] [Full Text] [Related]

  • 16. [HMG-CoA reductase inhibitors].
    Yamamoto A.
    Nihon Rinsho; 2001 Mar 26; 59 Suppl 3():578-86. PubMed ID: 11347135
    [No Abstract] [Full Text] [Related]

  • 17. [Goal in hypercholesterolemia: lowering LDL cholesterol level by 50%].
    MMW Fortschr Med; 2005 Jul 07; 147(27-28):51. PubMed ID: 16041948
    [No Abstract] [Full Text] [Related]

  • 18. [Ezetimib as combination partner in hypercholesteremia. Lowering LDL beyond the effect of statins].
    Sudhop T, von Bergmann K.
    MMW Fortschr Med; 2003 Apr 17; 145(16):48-50. PubMed ID: 14606402
    [No Abstract] [Full Text] [Related]

  • 19. [Decreasing LDL level moderately or drastically. Is differential therapy with statins available? (interview by Dirk Einecke)].
    März W.
    MMW Fortschr Med; 2004 Jul 08; 146(27-28):53. PubMed ID: 15526673
    [No Abstract] [Full Text] [Related]

  • 20. [What is assured in therapy with HMG-CoA reductase inhibitors (cholesterol synthesis inhibitors)?].
    Knisel W, Eggstein M.
    Internist (Berl); 1989 Dec 08; 30(12):776-83. PubMed ID: 2695487
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.